Harel A.
NanoMed Targeting Systems Inc., US
Keywords: atrial fibrillation, nano magnet particles, nanotechnology
NanoMed Targeting Systems (NTS) is developing magnetically targeted drug delivery systems for treating atrial fibrillation. This platform system is based on proprietary superparamagnetic nanoparticles attached to the payload, and its non-invasive proprietary magnetic guiding system. Atrial fibrillation (AF), the most common heart rhythm disorder, is a leading cause of strokes. With the aging population, the number of AF patients in the U.S. is expected to increase to ~16 million by 2050. AF treatment often requires expensive, long-term and risky anticoagulation to prevent strokes. Under current techniques, nearly half the patients will become drug-refractory and most will require interventions such as catheter ablations—the current standard of care. Ablations carry risks of serious complications and are very costly (5-year success
Journal: TechConnect Briefs
Volume: 3, Biotech, Biomaterials and Biomedical: TechConnect Briefs 2017
Published: May 14, 2017
Pages: 64 - 66
Industry sector: Medical & Biotech
Topics: Biomaterials, Materials for Drug & Gene Delivery
ISBN: 978-0-9988782-0-1